Hegde Shivanand, Hegde Shrilakshmi, Spergser Joachim, Brunthaler René, Rosengarten Renate, Chopra-Dewasthaly Rohini
Division of Clinical Microbiology and Infection Biology, Institute of Bacteriology, Mycology and Hygiene, Department of Pathobiology, University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria.
Institute of Pathology and Forensic Veterinary Medicine, Department of Pathobiology; University of Veterinary Medicine, Veterinaerplatz 1, A-1210 Vienna, Austria.
Int J Med Microbiol. 2014 Nov;304(8):1024-31. doi: 10.1016/j.ijmm.2014.07.011. Epub 2014 Jul 27.
Generally regarded as extracellular pathogens, molecular mechanisms of mycoplasma persistence, chronicity and disease spread are largely unknown. Mycoplasma agalactiae, an economically important pathogen of small ruminants, causes chronic infections that are difficult to eradicate. Animals continue to shed the agent for several months and even years after the initial infection, in spite of long antibiotic treatment. However, little is known about the strategies that M. agalactiae employs to survive and spread within an immunocompetent host to cause chronic disease. Here, we demonstrate for the first time its ability to invade cultured human (HeLa) and ruminant (BEND and BLF) host cells. Presence of intracellular mycoplasmas is clearly substantiated using differential immunofluorescence technique and quantitative gentamicin invasion assays. Internalized M. agalactiae could survive and exit the cells in a viable state to repopulate the extracellular environment after complete removal of extracellular bacteria with gentamicin. Furthermore, an experimental sheep intramammary infection was carried out to evaluate its systemic spread to organs and host niches distant from the site of initial infection. Positive results obtained via PCR, culture and immunohistochemistry, especially the latter depicting the presence of M. agalactiae in the cytoplasm of mammary duct epithelium and macrophages, clearly provide the first formal proof of M. agalactiae's capability to translocate across the mammary epithelium and systemically disseminate to distant inner organs. Altogether, the findings of these in vitro and in vivo studies indicate that M. agalactiae is capable of entering host cells and this might be the strategy that it employs at a population level to ward off the host immune response and antibiotic action, and to disseminate to new and safer niches to later egress and once again proliferate upon the return of favorable conditions to cause persistent chronic infections.
支原体通常被视为细胞外病原体,但其持续存在、慢性感染及疾病传播的分子机制在很大程度上尚不清楚。无乳支原体是小型反刍动物的一种重要经济病原体,可引发难以根除的慢性感染。尽管进行了长期抗生素治疗,动物在初次感染后的数月甚至数年仍会持续排出病原体。然而,对于无乳支原体在免疫功能正常的宿主体内生存和传播以引发慢性疾病所采用的策略,我们知之甚少。在此,我们首次证明了它具有侵入培养的人源(HeLa)和反刍动物源(BEND和BLF)宿主细胞的能力。利用差异免疫荧光技术和定量庆大霉素侵入试验,明确证实了细胞内支原体的存在。在用庆大霉素完全清除细胞外细菌后,内化的无乳支原体能够存活并以活的状态离开细胞,重新在细胞外环境中繁殖。此外,进行了一项实验性绵羊乳房内感染,以评估其向远离初始感染部位的器官和宿主微环境的全身扩散情况。通过PCR、培养和免疫组织化学获得的阳性结果,尤其是后者显示在乳腺导管上皮细胞和巨噬细胞的细胞质中存在无乳支原体,清楚地首次正式证明了无乳支原体能够穿过乳腺上皮并全身扩散至远处的内部器官。总之,这些体外和体内研究的结果表明,无乳支原体能够进入宿主细胞,这可能是它在群体水平上采用的策略,以抵御宿主免疫反应和抗生素作用,并传播到新的、更安全的微环境中,以便在有利条件恢复时再次逸出并增殖,从而引发持续的慢性感染。